Hjem › Neuroblastom › Maryland
Kliniske studier for Neuroblastom i Maryland
8 studier for Neuroblastom søker deltakere på steder i Maryland.
Byer i Maryland
Offisiell studietekst (engelsk)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- og 1 flere
RekruttererFase 3
Opp til 30 år · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06172296Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
4 Weeks · Alle kjønn · Oppdatert 2. okt. 2026 · NCT01109394Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 1
Alder 3 til 35 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06995872Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservasjonsstudie
Alder 4 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT01005654Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
RekruttererFase 3
365 Days – 30 Years · Alle kjønn · Oppdatert 25. aug. 2026 · NCT03126916SPEARHEAD-3 Pediatric Study
- National Institutes of Health, Bethesda
RekruttererFase 1/2
Alder 2 til 21 · Alle kjønn · Oppdatert 11. aug. 2026 · NCT05642455A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 1
Alder 18 til 120 · Alle kjønn · Oppdatert 15. jun. 2026 · NCT06041516Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
RekruttererFase 2
Alder 1 til 50 · Alle kjønn · Oppdatert 13. mar. 2026 · NCT01804634Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.